Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
Portfolio Pulse from
Quoin Pharmaceuticals Ltd. has announced a $6.8 million public offering, involving 15,111,110 ordinary shares represented by ADSs and warrants, priced at $0.45 per ADS. The Series F and G warrants have a $0.45 exercise price, expiring in two and five years, respectively.
December 20, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Quoin Pharmaceuticals has announced a $6.8 million public offering, which includes shares and warrants priced at $0.45. This could lead to short-term stock price volatility.
The public offering at a low price of $0.45 per ADS and warrants may lead to dilution of existing shares, potentially causing downward pressure on the stock price in the short term. The offering's size and pricing suggest a need for capital, which can be perceived negatively by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100